ActuityMD, a Boston, MA-based technology partner to the commercial MedTech industry, raised $45M in Series B funding.
The round, which brought the total amount to $83M, was led by ICONIQ Growth, with participation from Atreides Management and Stepstone Group, as well as existing investors Redpoint Ventures, Benchmark Capital, and Artisanal Ventures.
The company intends to use the funds to expand its commercial intelligence platform and advance its mission of accelerating adoption of medical technology.
Led by CEO Michael Monovoukas, AcuityMD provides a commercial intelligence platform to medical technology manufacturers. The platform translates large volumes of healthcare data, such as physician procedural volumes, product preferences, sites of care affiliations, peer networks, and referral patterns into workflows and recommendations that align with the MedTech industry’s commercial process. Over 200 companies, ranging from pre-commercial to enterprise, use its commercial platform to identify target markets, surface top opportunities, and grow their business.
To date, AcuityMD has raised more than $83m and achieved a significant 10x increase in annual recurring revenue since its 2022 Series A raise.
FinSMEs
04/06/2024